Alliances
Namocell Inc. announced that it has entered into a collaboration with Takara Bio and HepaTx to use Namocell’s Single Cell Dispensers to perform single cell isolation on HepaTx’s unique hepatocyte-like cells developed from adipose tissue-derived stromal cells, and characterize them by single cell RNA-seq using Takara Bio’s SMART-Seq technology.
Immatics is eligible for more than $550 million in various commercial milestone payments for each product as well as additional royalties.
Microbiome specialist MRM Health enters into its first industry collaboration with DuPont Nutrition & Biosciences in the field of metabolic diseases.
MRM Health also announced that it raised more than €14m to advance its clinical and preclinical development programs in the field of microbiome-based therapeutics with partner participation.
DNX Biopharmaceuticals announced that it has entered into a strategic collaboration with the Lung Cancer Initiative at Johnson & Johnson*.
To date, there are more than 72,000 confirmed and suspected cases of COVID-19 and 1,023 deaths from COVID-19, most in mainland China.
Agreement capitalizes on artificial intelligence and deep learning to develop therapeutic monoclonal antibodies, including novel bispecific antibodies (BiCKI® platform)
Founded in 2018 and based in Lausanne Epalinges at BIOPOLE in Switzerland, Deep Cube SA specializes in developing innovative artificial intelligence technology based on Deep Learning.
Evgen Pharma (Evgen) and The University of Rochester School of Medicine and Dentistry have entered into a Memorandum of Understanding to advance SFX-01 towards a clinical trial in chronic kidney disease (CKD).
WindMIL Therapeutics and Providence Cancer Institute announced that the first patient has been identified in an investigator-sponsored study for the collection of bone marrow from patients with breast cancer.
PRESS RELEASES